Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.
- DOI
- 10.1186/s12885-022-09687-x
- Published
- 2022 Jun 7
- Container
- BMC cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-022-09687-x,
title = {Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.},
author = {Yang JCH and Brose MS and Castro G and Kim ES and Lassen UN and Leyvraz S and Pappo A and López-Ríos F and Reeves JA and Fellous M and Penault-Llorca F and Rudzinski ER and Tabatabai G and Vassal G and Drilon A and Trent J},
year = {2022},
journal = {BMC cancer},
doi = {10.1186/s12885-022-09687-x},
url = {https://doi.org/10.1186/s12885-022-09687-x}
}RIS
TY - JOUR TI - Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib. AU - Yang JCH AU - Brose MS AU - Castro G AU - Kim ES AU - Lassen UN AU - Leyvraz S AU - Pappo A AU - López-Ríos F AU - Reeves JA AU - Fellous M AU - Penault-Llorca F AU - Rudzinski ER AU - Tabatabai G AU - Vassal G AU - Drilon A AU - Trent J PY - 2022 JO - BMC cancer DO - 10.1186/s12885-022-09687-x UR - https://doi.org/10.1186/s12885-022-09687-x ER -
APA
JCH, Y., MS, B., G, C., ES, K., UN, L., S, L., A, P., F, L., JA, R., M, F., F, P., ER, R., G, T., G, V., A, D., & J, T. (2022). Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.. BMC cancer. https://doi.org/10.1186/s12885-022-09687-x
Source records
- pubmed · retrieved 2026-09-26T23:18:03.120Z